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REPORT
The Discovery of a LEMD2-Associated Nuclear
Envelopathy with Early Progeroid Appearance Suggests
Advanced Applications for AI-Driven Facial Phenotyping
Felix Marbach,1,2,19 Cecilie F. Rustad,3,19 Angelika Riess,4,19 Dejan ukic,5 Tzung-Chien Hsieh,6
Itamar Jobani,7 Trine Prescott,8 Andrea Bevot,9 Florian Erger,1,2 Gunnar Houge,10,11 Maria Redfors,12,13
Janine Altmueller,14 Tomasz Stokowy,11 Christian Gilissen,15 Christian Kubisch,16 Emanuela Scarano,17
Laura Mazzanti,17 Torunn Fiskerstrand,10,11,18 Peter M. Krawitz,6 Davor Lessel,16,20
and Christian Netzer1,2,20,*
Over a relatively short period of time, the clinical geneticist’s ‘‘toolbox’’ has been expanded by machine-learning algorithms for image
analysis, which can be applied to the task of syndrome identification on the basis of facial photographs, but these technologies harbor
potential beyond the recognition of established phenotypes. Here, we comprehensively characterized two individuals with a hitherto
unknown genetic disorder caused by the same de novo mutation in LEMD2 (c.1436C>T;p.Ser479Phe), the gene which encodes the nu-
clear envelope protein LEM domain-containing protein 2 (LEMD2). Despite different ages and ethnic backgrounds, both individuals
share a progeria-like facial phenotype and a distinct combination of physical and neurologic anomalies, such as growth retardation;
hypoplastic jaws crowded withmultiple supernumerary, yet unerupted, teeth; and cerebellar intention tremor. Immunofluorescence an-
alyses of patient fibroblasts revealed mutation-induced disturbance of nuclear architecture, recapitulating previously published data in
LEMD2-deficient cell lines, and additional experiments suggested mislocalization of mutant LEMD2 protein within the nuclear lamina.
Computational analysis of facial features with two different deep neural networks showed phenotypic proximity to other nuclear en-
velopathies. One of the algorithms, when trained to recognize syndromic similarity (rather than specific syndromes) in an unsupervised
approach, clustered both individuals closely together, providing hypothesis-free hints for a common genetic etiology. We show that a
recurrent de novomutation in LEMD2 causes a nuclear envelopathy whose prognosis in adolescence is relatively good in comparison to
that of classical Hutchinson-Gilford progeria syndrome, and we suggest that the application of artificial intelligence to the analysis of
patient images can facilitate the discovery of new genetic disorders.
Nuclear envelopathies are rare disorders caused by muta-
tions in genes encoding proteins of the nuclear envelope
(NE); these mutations result in a variety of phenotypes,
some of which mimic aspects of human aging.1 A proto-
typical example is Hutchinson-Gilford progeria syndrome
(HGPS, MIM: 176670), which is typically accompanied by
early-onset atherosclerosis, leading to cardiovascular com-
plications and mortality in the late second decade of life
(see Web Resources).2 It is caused by a recurrent de novo
synonymous splicing mutation in LMNA (MIM: 150330),
which encodes the splicing isoforms lamin A and C
(A-type lamins), the main components of the nuclear lam-
ina in somatic cells.3 Many other proteins are ‘‘anchored’’
within the meshwork created by lamins, and some of the
respective genes, such as LEMD3 (also known as MAN1
[MIM: 607844]), BANF1 (MIM: 603811), and EMD (MIM:
300384), are associated with nuclear envelopathies (see
Web Resources).4,5 At the cellular level, mutations in these
genes cause disruption of the nuclear architecture and
gene regulation. The integral NE protein LEMD2 (LEM
domain-containing protein 2) is functionally and physi-
cally linked to A-type lamins, and experimental data sug-
gest it has a role in the structural organization of the NE6
as well as chromatin binding and distribution.7,8 Although
a single LEMD2 founder mutation has been implicated in
an autosomal-recessive form of congenital cataracts
(MIM: 212500),9 LEMD2 has not been associated with a
complex syndromic phenotype to date.
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We performed molecular analyses and artificial-intelli-
gence-driven facial phenotyping on two individuals who
are of different ethnicities and share similar facial features
and physical anomalies. Both individuals and their families
gave their written informed consent to participate in this
study and to undergo facial analysis by specialized software
(University ofCologne).Genetic analyseswere approvedby
the ethics committees of the University of Cologne (indi-
vidual 1) and the Regional Committee for Medical and
Health Research Ethics in Western Norway (individual 2).
Individuals 1 and 2 presented at different university hos-
pitals (Bologna, Italy and Oslo, Norway). Because of the
individuals’ early progeria-like appearance with little sub-
cutaneous fat and triangular facies, clinicians suspected
HGPS during the first years of life in both cases. However,
the individuals’ further development was encouraging,
and the initial suspected diagnosis was discarded because
neither developed joint contractures, alopecia, or clinical
signs of atherosclerosis. Psychomotor development was
normal, but poor linear growth was noted. Both had
severely delayed dentition with crowded, mostly unerup-
ted teeth in the upper and lower jaw (Figure 1C). Oral
food intake was perturbed in both cases, necessitating sup-
plementation via gastrostomy for individual 2 from the age
of 3 years onward.
At the time of their last clinical evaluations at the ages of
16 and 10 years, respectively, individuals 1 and 2 had
microcephaly, protruding eyes, and mandibular hypopla-
sia along with hypodontia (Figures 1A–1C). Prominent
veins and a paucity of subcutaneous fat were notable in
both, although these characteristics were more pro-
nounced in individual 1. Skeletal features included
wormian bones and hypoplastic clavicles, as well as
reduced bone mineral density in the case of individual 1.
Both had normal cognition but cerebellar intention tremor
and mildly reduced muscle strength. Cranial MRIs of
individual 1 had revealed white-matter hyperintensities
of the peritrigonal area at the age of 5 and diffuse hyperin-
tensities of the cerebral white matter at the age of 14, indi-
cating progressive hypomyelination (Figure S1A). A cranial
MRI of individual 2 at the age of 22 months did not show
white-matter irregularities. Whereas, in the case of individ-
ual 2, growth hormone (GH) therapy initiated at age 4
substantially improved linear growth, GH therapy begin-
ning at age 11 seemed to be ineffective for individual #1
and was discontinued after 19 months because of newly
occurring insulin resistance. Repeated ophthalmological
examination of both individuals revealed no significant
pathologies.
Family history of both individuals was negative for
similar symptomatology, and there was no history of con-
sanguinity. More detailed descriptions of the clinical
histories of individuals 1 and 2 can be found in the
Supplemental Data. A compilation of the phenotypes in
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Figure 1. Clinical Phenotype and Image
Analysis of Individuals 1 and 2
(A) Facial phenotypes of individuals 1 (left)
and 2 (right). Individual 1 is shown at the
ages of 16 years (upper panel) and 3 years
(lower panel); individual 2 is shown at
the ages of 10 years and 2 years (upper
and lower panel, respectively). Note the
protruding eyes; small mandibula and
oral aperture; and triangular face of both
individuals; this latter feature is more pro-
nounced at a younger age.
(B) (Left to right) The profiles of individ-
uals 1 and 2 as seen at the ages of 16 and
11 years, respectively.
(C) Dental features of individuals 1 and 2.
Left panel: A cranial X-ray of individual 1
shows crowded, unerupted teeth in the up-
per and lower jaw at the age of 13 years.
Right panels: Cranial CBCT scans of
individual 2 revealed complete non-erup-
ted primary dentition and agenesis of mul-
tiple teeth in the non-erupted permanent
dentition in the mandible at the age of
9 years.
(D) Composite images for LEMD2 and
HGPS were averaged from photos of both
individuals (left) and HGPS patients
(right), as described in the Supplemental
Material and Methods, and manually re-
touched.
(E) Histogram of the pairwise distances
among all cases of the cohort. Compari-
sons of the same disease entity were used
for adding a red blend to the respective bins according to their proportion. At the left side of the distribution, where the two individuals
with the LEMD2 mutation are also posed, the percentage of pairs with the same disease-causing gene increases.
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comparison to those associated with HGPS,2 the segmental
progeroid disorders known as Ne´stor-Guillermo progeria
syndrome (MIM: 614008),4 and PYCR1-related auto-
somal-recessive cutis laxa (MIM: 612940),10 to which
high facial similarity to individual 1 and 2 was calculated
by FaceNet (see Figure S2B), is shown in Table1. Of note,
PYCR1-related autosomal-recessive cutis laxa has recently
been reported to display significant clinical similarities to
HGPS, predominantly in the first years of life.11
Individual 1 had undergone molecular genetic testing of
LMNA and ZMPSTE24 (MIM: 606480) prior to recruitment
for the research study, and individual 2 had received
Table 1. Compilation of Phenotypic Features of Both Individuals in Comparison to Those of Classical HGPS, NGPS, and PYCR1-Related
Autosomal-Recessive Cutis Laxa
Disorder
LEMD2-Associated
Nuclear
Envelopathy,
Individual 1
LEMD2-Associated
Nuclear
Envelopathy,
Individual 2
Hutchinson-
Gilford Progeria
Syndrome
Ne´stor-Guillermo
Progeria
Syndrome
PYCR1-Related
Autosomal
Recessive
Cutis Laxa
Gene, Protein(s) LEMD2, LEM
domain-containing
protein 2
LEMD2, LEM
domain-containing
protein 2
LMNA, lamin A
and C
BANF1, barrier-to-
autointegration
factor
PYCR1, pyrroline-
5-carboxylate
reductase 1
Facial Features Triangular face þþþ þþþ þþ þ þþþ
Prominent eyes þþþ þþþ þþþ þþþ þþ
Crooked nose, septum
deviation
þþþ þ þþ þþþ -
Mandibular hypoplasia þþþ þþ þþ þþþ -
Skin, Hair,
Nails, and
Juvenile alopezia - - þþþ þþ -
Subcutaneous
Tissue
Loss of eyebrows - - þþþ - -
Thin skin, prominent veins þ þþ þþþ þþþ þþ
Cutis laxa - - - - þþþ
Patchy hyperpigmentation - - þ þ -
Dystrophic nails - - þ þ -
Generalized lipoatrophy þþ þ þþþ þþ -
Skull and Dentures Microcephaly þþþ þþ þþ - þ
Wormian bones þþþ þþþ - - þ
Open cranial sutures - - - þþþ -
Dental crowding þþþ þþþ - þþþ -
Supernumerary teeth þþþ þþþ - - -
Delayed dentition þþþ þþþ þ - -
Skeletal Features Short stature þþþ -a þþþ þþþ þ
Low bone density þþ - þþ þþþ þþ
Hypoplastic clavicles þþ þþ þþ þþþ -
Osteolytic foci - - þþ þþþ -
Joint hyperlaxity - - - - þþ
Limited joint mobility - - þþ þþþ -
Other Features IUGR þ - - - þþ
Atherosclerosis - - þþþ - -
Intention tremor þþ þþ - - -
Developmental delay - - - - þþ
Compilation of phenotypic features of both individuals in comparison to those of classical Hutchinson-Gilford Progeria Syndrome (HGPS), the phenotypically over-
lapping Ne´stor-Guillermo Progeria Syndrome (NGPS), and PYCR1-related autosomal-recessive cutis laxa, to which a high facial similarity was demonstrated upon
image analysis. The novel LEMD2-associated phenotype has a characteristic and distinctive pattern of features involving several organ systems but still displaying
the highest similarity to the nuclear envelopathies NGPS and HGPS.
aNormal height (32th percentile) after GH-Treatment beginning at the age of 4 years.
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testing for LMNA and an SNP chromosomal microarray.
Because these tests could not provide an explanation for
the unusual phenotypes, trio-exome sequencing of both
individuals and their parents was performed (see Supple-
mental Materials and Methods for details). The German
and Norwegian research groups independently identified
the de novo missense variant c.1436C>T, (p. Ser479Phe)
(GenBank: NM_181336.3) in LEMD2, which results in
the substitution of serine with phenylalanine at position
479 (Figure 2A), as potentially causative. When both
groups came into contact through GeneMatcher, a web-
based tool for researchers and clinicians working on the
same genes,12 the fact that both individuals carried the
identical de novo variant as well as striking similarities in
appearance and medical history became apparent. Given
the rarity of de novo mutations in the protein-coding part
of the genome, the causal role of the LEMD2 variant was
established at this stage; the likelihood of finding the
same de novo variant—by chance—in two individuals
with a distinct and similar phenotype is negligibly low.13
We estimate this likelihood to be approximately 1 in
60 million (see Supplemental Note 2 for further details).
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Figure 2. Cellular Phenotype of Patient Fibroblasts
(A) Sanger Sequencing of exon 9 of LEMD2 in individual 1 and his parents shows the c.1436C>T de novo mutation in a heterozygous
state. The resulting amino acid change p.Ser479Phe is indicatedwithin the amino acid sequence of LEMD2. TheN-terminal LEMdomain
(IPR011015), which mediates DNA binding through barrier-to-autointegration factor (BAF) proteins, and the mutated amino acid posi-
tion within the C-terminal nucleoplasmic domain are highlighted. The image was generated with the Protter website (see Web
Resources).
(B and C) Nuclear abnormalities in patient fibroblasts compared to control fibroblasts can be seen acrossmultiple different IF stainings of
NE proteins: stainings of lamin A and C, Emerin, BANF1, and LAP1B (TOR1AIP1) reveal irregular shapes, ‘‘blebbing’’ (red arrow), and
invaginations (white arrows) of the nuclear membrane in patient fibroblasts (representative images).
(D) Quantification of nuclear anomalies in primary fibroblasts shows a significantly higher percentage of abnormal nuclei in both in-
dividuals’ fibroblasts as compared to cells from healthy controls. The combined results (mean 5 SEM) of three separate experiments
are shown (** ¼ p% 0.01, *** ¼ p% 0.001).
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As is to be expected for the causal variant in an ultra-
rare disease, the variant c.1436C>T was absent from
the ExAC and gnomAD databases. The algorithms
MutationTaster, PolyPhen-2, and SIFT predicted the
variant to be disease causing, probably damaging, and
damaging, respectively. The CADD score was calculated
as 32.000, a value strongly suggesting deleteriousness of a
variant. The fact that neither affected individuals carried
a second rare variant in LEMD2 suggests an autosomal-
dominant mode of inheritance of the phenotype. Of
note, the Hutterite founder mutation p.Leu13Arg
(c.38T>G), which causes an autosomal-recessive type of ju-
venile-onset cataract (accompanied by sudden cardiac
death at an early age in some individuals), affects an amino
acid within the N-terminal LEM domain, whereas the
variant p.Ser479Phe (c.1436C>T) is located at the C termi-
nus of LEMD2 (Figure 2A). Viewed from a more global
perspective, the number of observed LEMD2missense var-
iants (irrespective of their allele frequency) in the ExAC
and gnomAD databases is lower than the number of theo-
retically expected variants14 for this gene: the missense
Z score taken from the constraint metric for LEMD2 is
3.65 in ExAC (203.3 expected and 97 observed missense
variants) and 1.98 in gnomAD (226.2 expected and 144
observed), indicating a relatively high degree of evolu-
tionary intolerance to missense variation.
Considering the well-established role of LEMD2 in the
maintenance of nuclear membrane morphology15 and
LEMD2’s previously reported association with lamin A
and emerin,6,16 we performed immunofluorescence anal-
ysis of patient-derived fibroblasts and fibroblasts of two
healthy control individuals (see Supplemental Material
and Methods for experimental details). This analysis,
through the use of four well-established integral members
of the NE (lamin A and C, emerin, BANF1, and LAP1B), re-
vealed significantly increased numbers of abnormal nuclei
in both patient cell lines when compared to the control
cell lines (Figures 2B–2D), although all four investigated
proteins showed correct intracellular localization. These re-
sults were similar to previous findings in HGPS cells.17
Notably, although we observed some nuclear blebs and
complex nuclear abnormalities, the gross majority
(80%–90%) of nuclear abnormalities in fibroblasts from
both individuals were invaginations of the NE (Figure 2B,
white arrows). These data recapitulate findings in
LEMD2-deficient cell lines,15 providing additional evi-
dence for the pathogenic nature of the here identified
LEMD2 variant.
We further tried to evaluate the localization of LEMD2 in
patient fibroblasts compared to control fibroblasts. How-
ever, both tested antibodies gave unspecific staining (data
not shown). We therefore turned to a U2OS transient
transfection system. Overexpression of wild-type (WT)
and mutant LEMD2-FLAG constructs in U2OS cells led to
frequent formation of ‘‘patches’’ of LEMD2 within the nu-
clear periphery, as previously described.6 However, trans-
fection with small amounts of plasmid DNA (125 ng/mL)
resulted in smooth distribution and good overall co-local-
ization with lamin A and C in the case of WT LEMD2,
whereas patchy accumulations remained predominant in
cells transfected with mutant LEMD2 (Figures 3A and
3B). This visual impression was validated by quantitative
co-localization analysis (Figure 3C). Both WT and mutant
LEMD2-FLAG constructs were largely restricted to the nu-
cleus, and immunoblotting showed no differences in
spatial distribution within the cell (Figure 3D). The notion
thatmutant LEMD2 accumulates in direct contact with the
nuclear lamina was further supported by co-localization of
mutant andWT LEMD2-FLAG constructs with the lamina-
associated proteins emerin and BANF1 (Figures 3E–3G).
The preferential formation of ‘‘patches’’ suggests a misloc-
alization of mutant LEMD2 within the NE, which is in
accordance with the observation of invaginations of the
nuclear membrane in patient fibroblasts.18 Taken together,
these data suggest that this disorder is a nuclear envelop-
athy on the cellular level.
When the German group analyzed frontal photographs
of individual 1 in early 2017 by using Face2Gene, the
well-established nuclear envelopathy HGPS was listed
among the most likely diagnoses, and later image analysis
of individual 2 produced similar results. We considered it
an intriguing finding that DeepGestalt,19 this website’s
deep convolutional neural network, which is commonly
used as an aid to diagnosis in patients with known disor-
ders, correctly assigned a novel syndrome to a group of
syndromes for which facial similarity suggested an overlap-
ping pathogenesis. Both individuals’ DeepGestalt similar-
ity scores for known disorders, as well as the overlap
between the individual DeepGestalt similarity scores with
regard to each disorder, are shown on a radar plot in
Figure S2A. DeepGestalt was trained via a supervised
learning process to assign patient pictures to a set of 216
syndromes it had ‘‘learned’’ to recognize beforehand. In or-
der to visualize the results of the DeepGestalt analysis, we
generated composite masks of both syndromes. These
masks demonstrate facial similarities and differences be-
tween individuals 1 and 2 and patients with HGPS
(Figure 1D).
Because the genetic disorder of individual 1 and 2 was
previously unknown, we decided to also investigate the
similarity between both cases in an unsupervised, data-
driven way. To do this, we clustered patient photos by us-
ing the neural network FaceNet,20 which was initially
trained to recognize intra-personal similarity in a large
dataset of unconstrained facial photos (i.e., in a non-
medical context). After being trained to recognize intra-
syndromal similarity in a group of 265 individuals with
facial abnormalities from 66 different monogenic syn-
dromes that had been selected from the PEDIA cohort
(T.-C. H. et al., unpublished data), FaceNet found
individuals 1 and 2 to be not only almost the most similar
among 34,980 random pairwise comparisons but also
more similar than most individuals inside other disease
entities, including some related individuals (Figure 1E).
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Figure 3. Immunofluorescence Analysis of Mutant LEMD2 in U2OS Cells
(A) Irregular nuclear localization of mutant LEMD2 during transient overexpression with pCMV6-LEMD2-FLAG constructs containing
either the LEMD2 WT or mutant (c.1436C>T) sequence in U2OS cells. 48 h after transfection, immunofluorescence staining of FLAG
(green) and lamin A and C (red) reveals patchy accumulations of mutant LEMD2 (white arrows), whereas the WT construct shows
more even distribution within the nuclear lamina.
(B) Manual comparison of cells transfected withWTand mutant LEMD2 constructs shows a higher percentage of abnormal distribution
in cells transfected with mutant LEMD2. Nuclear distribution of LEMD2 was characterized as normal or irregular, and the percentage of
nuclei with irregular distribution was calculated. Combined results (mean5 SEM) of three separate experiments are shown. (A total of
225 cells transfected with WT and 209 cells transfected with mutant LEMD2 were analyzed.)
(C) Quantitative colocalization analysis ofWTandmutant LEMD2 demonstrates disturbed colocalization ofmutant LEMD2 and lamin A
and C. Nuclei of cells transfected with both constructs (pCMV6-LEMD2-FLAG WT and mutant) were delimited and analyzed with the
ImageJ software (Coloc2 plugin). The Pearson correlation coefficients of LEMD2-FLAG and lamin A and C of each individual nucleus, as
well as averages and p values (according to the Wilcoxon rank sum test with continuity correction), are shown.
(D) WT and mutant LEMD2 are both predominantly localized within the nucleus. The Subcellular Protein Fractionation Kit (Thermo
Fisher) was used to collect fractionated cell lysates 48 h after transfection withWTandmutant LEMD2 constructs. Immunoblot analysis
revealed similar distribution patterns of both WT and mutant LEMD2 within cytoplasm (Cyto), membranes (Mem), and nuclear (Nuc)
fractions. Comparison of band intensity normalized for total protein (shown as x-fold change with regard to the normalized band in-
tensity of the cytoplasm fraction) from three separate experiments (mean5 SEM) did not reveal significant differences betweenWTand
mutant constructs.
(E–G) Proteins of the nuclear lamina display different localization patterns relative to LEMD2-FLAG constructs. U2OS cells were trans-
fected through the use of pCMV6-LEMD2-FLAG constructs (WT or mutant), and immunofluorescence stainings were performed 48 h
after transfection. Whereas emerin and BANF1 colocalize with irregular nuclear accumulations of mutant LEMD2 (E and F), LAP1B
does not (G).
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A close-up of the dendrogram of the cophenetic distances
of the clustering analysis is shown in Figure S2B. We
concluded that FaceNet could determine, solely on the
basis of the facial phenotype, that individuals 1 and 2
were probably affected by the same syndrome and that
DeepGestalt recognized that this particular phenotype
was similar to that of the family of early-onset segmental
progeroid syndromes. More details about the techniques,
including the cluster analysis, can be found in the Supple-
mental Data.
The LEMD2-associated disorder presented in this report
displays a distinct combination of symptoms and has
phenotypic overlap with other established segmental
progeroid syndromes, such as HGPS, mandibuloacral
dysplasia (MIM: 248370, 608612), and Ne´stor-Guillermo
Progeria syndrome. However, it is important to note
the better overall prognosis of the LEMD2-associated
disorder when compared to HGPS: individual 1 is now
19 years of age and without clinical signs of atheroscle-
rosis, and neither patient currently presents with life-
limiting symptoms.
The available data on LEMD2,6–8,15,16,21 combined with
the individuals’ phenotypes and our own observations
in vitro, strongly support our hypothesis of an LEMD2-asso-
ciated syndromic nuclear envelopathy. The maintenance
of nuclear morphology is a well-documented function of
LEMD2 in vitro: it is required for reformation and closure
of the NE during anaphase in mitotic yeast and HeLa
cells,21 high-level overexpression of LEMD2 led to the for-
mation of finger-type intrusions in the nuclear membrane
of HeLa cells,6 and invaginations and lobulations of the NE
have been reported upon siRNA-mediated depletion of
LEMD2 in HeLa and U2OS cells.15 Thus, the nuclear anom-
alies in patient fibroblasts (Figure 2B) recapitulate the find-
ings in the above-mentioned LEMD2-deficient cell lines,15
and these anomalies might be attributable to the observed
irregular accumulations of mutant LEMD2 in the NE.
Besides having an established role in the maintenance of
NE integrity, LEMD2 has additionally been implicated in
several other mutually non-exclusive biological processes
and signaling pathways, including telomere anchoring
and heterochromatin silencing,22 DNA replication,23 and
MAPK cascade and ERK signaling.24 However, elucidation
of the impact of the p.Ser479Phe variant in these processes
as well as those linked to other progeroid syndromes will
require further work and will be the main focus of our
future studies.
Traditionally, recognition and classification of facial dys-
morphology are among the key skills of a clinical geneti-
cist. What used to require decades of training and clinical
experience is now being supplemented by the introduc-
tion of image-analysis algorithms into clinical practice.
For diagnoses with sufficiently distinct facial phenotypes,
algorithms employing machine learning generally fare
well in prioritizing potential diagnoses, sometimes with
even better accuracy than that of seasoned geneti-
cists.19,25,26 Another not-yet-exploited utility of these tech-
nologies is their potential to detect similarities of novel
phenotypes to known disorders and to thereby identify a
potential molecular etiology, such as the disruption of a
signaling pathway or a specific cellular compartment. In
our case, DeepGestalt recognized the facial similarity of
individuals with the LEMD2 mutation c.1436C>T to
individuals with another nuclear envelopathy, HGPS.
Furthermore, FaceNet, when trained accordingly to detect
intra-syndromal similarity, correctly perceived that these
two individuals have highly similar facial dysmorphology.
Both neural networks thus provided supporting evidence
for gene identification in our particular case. We suggest
that, in particular, FaceNet’s ability to form groups within
a cohort of syndromic patients constitutes a hypothesis-
free approach to syndrome identification and patient
matching and that this approach could even help to iden-
tify individuals with ultra-rare or previously unknown
disorders (e.g. via a web-based patient-matching tool).
Such image-analysis algorithms could be employed in the
detection of syndromic ‘‘kinship’’ between non-related in-
dividuals and in the delineation of syndrome families to
facilitate the discovery of new genetic disorders and under-
lying mutations, a concept that was suggested almost
15 years ago.27
In summary, we show that a recurrent de novo mutation
in LEMD2 causes a syndromic nuclear envelopathy with a
relatively good prognosis, and we suggest that the use of
artificial intelligence could facilitate the discovery of new
genetic disorders.
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